Pfizer Inc (PFE)

$24.24 +0.05 (0.21%)
Market Cap 137.53B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 7.55
Forward PE 7.92
Profit Margin 12.62%
Debt to Equity Ratio 0.69
Volume 44,584,274
Avg Vol 43,158,664
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 52%
Beta 0.57
Analysts Sell
Price Target $27.62

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
AndrewLonggg
AndrewLonggg Jun. 30 at 9:12 PM
$DJT $PFE $SPY Here is the funny thing. We no longer want to follow the old health expert advice. You would prefer not to follow the new health expert advice. Let’s both decide what we would prefer to do then
0 · Reply
WholeLottaLuv
WholeLottaLuv Jun. 30 at 9:11 PM
$DJT $PFE $SPY You mean the guy with the brain worm, who was a heroin addict for 14 years? Jesus says “Lying is Bad.” Better stop lying and posting MAGA lies, Andrew.
0 · Reply
Shagg85
Shagg85 Jun. 30 at 8:49 PM
$BMY $NUVB $NUVL $PFE $RHHBY pump on your Own ticker. they aren’t even close to release or FDA approval
0 · Reply
BeefSchnitzerlin
BeefSchnitzerlin Jun. 30 at 8:39 PM
$PFE Recent low bounced off the 35 year trendline...
2 · Reply
Quantumup
Quantumup Jun. 30 at 8:39 PM
Goldman Sachs assigned $NUVL at a Buy-$105 after its previous No Rating on their Initiation, plus⬆️its peak sales ests for nela/zide to ~$7B WW non-risk-adj'd, or ~$5B risk-adj'd in 2040. $NUVB $PFE $BMY $RHHBY Goldman Sachs said in its note:
0 · Reply
AndrewLonggg
AndrewLonggg Jun. 30 at 8:32 PM
$DJT $SPY $PFE BREAKING: Robert F. Kennedy Jr. says the CDC covered up an internal study which found a 1135% increase in autism risk from hepatitis B vaccine.
3 · Reply
taxplanr
taxplanr Jun. 30 at 8:26 PM
Texas gubernatorial candidate wants to arrest Fauci $BNTX $MRNA $PFE https://x.com/DiedSuddenly_/status/1939447328244462059
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 30 at 8:00 PM
$PFE Yet another EOD pump that gets shorted back down in the last 5 mins of trading
0 · Reply
_Crim_Jamer_
_Crim_Jamer_ Jun. 30 at 7:52 PM
$PFE my feelings as a $PFE investor.
1 · Reply
HFlier
HFlier Jun. 30 at 7:24 PM
$PFE I don't normally trash talk stocks I am long in, but this one has been such trash for no reason over the last year, I can't help myself. They have good performance and a good pipeline and PE is seriously attractive. But until the Greek moves on, I fear this will just languish. He does not excite the investment community. The activist investors should have worked harder to toss him out. The float is way too high to.
0 · Reply
Latest News on PFE
House committee subpoenas Pfizer executive in probe of alleged COVID vaccine delay, CNN reports

Jun 30, 2025, 4:01 PM EDT - 1 hour ago

House committee subpoenas Pfizer executive in probe of alleged COVID vaccine delay, CNN reports

XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations

Jun 29, 2025, 9:23 PM EDT - 19 hours ago

XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations

Pfizer's bleeding disorder therapy meets main goal in patients with certain antibodies

Jun 26, 2025, 7:23 AM EDT - 4 days ago

Pfizer's bleeding disorder therapy meets main goal in patients with certain antibodies

Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors

Jun 26, 2025, 6:45 AM EDT - 4 days ago

Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors

Pfizer Could Be The Turnaround Story In The Pharmaceutical Space

Jun 25, 2025, 11:57 PM EDT - 4 days ago

Pfizer Could Be The Turnaround Story In The Pharmaceutical Space

Pfizer Declares Third-Quarter 2025 Dividend

Jun 25, 2025, 5:30 PM EDT - 4 days ago

Pfizer Declares Third-Quarter 2025 Dividend

Don't Sleep On Pfizer: The Turnaround Is Just Getting Started

Jun 25, 2025, 2:15 PM EDT - 5 days ago

Don't Sleep On Pfizer: The Turnaround Is Just Getting Started

17 Ideal 'Safer' Dividend Dogs To Buy Out Of 72 June Graham Value All-Stars

Jun 25, 2025, 2:15 PM EDT - 5 days ago

17 Ideal 'Safer' Dividend Dogs To Buy Out Of 72 June Graham Value All-Stars

ARCC BCS BNS BXSL CALM COLB DHT

Top stock price forecast: Plug Power, Uber, and Pfizer

Jun 25, 2025, 12:06 PM EDT - 5 days ago

Top stock price forecast: Plug Power, Uber, and Pfizer

PLUG UBER

Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts

Jun 25, 2025, 10:00 AM EDT - 5 days ago

Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts

10 'Safer' Dividend Buys Of Barron's Better Bets Than T-Bills For June

Jun 24, 2025, 10:16 AM EDT - 6 days ago

10 'Safer' Dividend Buys Of Barron's Better Bets Than T-Bills For June

BBY BMY CAG EQR ETR FRT KEY

Pharma companies need to beef up M&A right now, says Mizuho's Jared Holz

Jun 23, 2025, 6:10 PM EDT - 6 days ago

Pharma companies need to beef up M&A right now, says Mizuho's Jared Holz

AMGN GPCR LLY NVO REGN VKTX XBI

The Dark Side Of Dividend Growth Investing

Jun 21, 2025, 8:05 AM EDT - 9 days ago

The Dark Side Of Dividend Growth Investing

ET LEG O T WBA WPC XIFR

I'm Buying Dividend Giants At Huge Discounts

Jun 20, 2025, 9:00 AM EDT - 10 days ago

I'm Buying Dividend Giants At Huge Discounts

ABBV BMY CVX OXY SHEL SLB TTE

Will Pfizer Slash Its >7% Yielding Dividend? I Wouldn't Rule It Out

Jun 20, 2025, 8:30 AM EDT - 10 days ago

Will Pfizer Slash Its >7% Yielding Dividend? I Wouldn't Rule It Out

Pfizer: An Offensive Play For A Bear Market

Jun 20, 2025, 4:41 AM EDT - 10 days ago

Pfizer: An Offensive Play For A Bear Market

RFK Jr weighs review of vaccines citing aluminum use, Bloomberg News reports

Jun 18, 2025, 1:05 PM EDT - 12 days ago

RFK Jr weighs review of vaccines citing aluminum use, Bloomberg News reports

MRK SNY

RFK Jr.'s new vaccine advisors will vote on flu shots containing mercury

Jun 18, 2025, 1:01 PM EDT - 12 days ago

RFK Jr.'s new vaccine advisors will vote on flu shots containing mercury

MRK SNY

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

Jun 18, 2025, 7:39 AM EDT - 12 days ago

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

MRK XRAY

50% Off - 2 Dividend Gems With Huge Income And Growth Potential

Jun 18, 2025, 7:30 AM EDT - 12 days ago

50% Off - 2 Dividend Gems With Huge Income And Growth Potential

REXR

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan

Jun 17, 2025, 10:00 AM EDT - 13 days ago

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan

ABBV AMGN JNJ MRK

Two Alternatives For A Potential $5000 Monthly Income

Jun 14, 2025, 8:05 AM EDT - 16 days ago

Two Alternatives For A Potential $5000 Monthly Income

ADX AES ARCC BTI CVX GLDM JAAA

Why Apple, Microsoft, Pfizer and other U.S. multinational corporations set up shop in Ireland

Jun 12, 2025, 12:10 PM EDT - 18 days ago

Why Apple, Microsoft, Pfizer and other U.S. multinational corporations set up shop in Ireland

AAPL MSFT

5 Ideal 'Safe' Buys From June Fortune Return On Leadership Screen

Jun 10, 2025, 12:47 PM EDT - 20 days ago

5 Ideal 'Safe' Buys From June Fortune Return On Leadership Screen

ACI BMY CMCSA COP CVS CVX EPD

RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say

Jun 10, 2025, 11:50 AM EDT - 20 days ago

RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say

BNTX MRK MRNA

Vaccine actions and policy positions under US Health Secretary Kennedy

Jun 10, 2025, 10:45 AM EDT - 20 days ago

Vaccine actions and policy positions under US Health Secretary Kennedy

BNTX MRNA NVAX

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

Jun 10, 2025, 9:30 AM EDT - 20 days ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

BNTX MRNA NVAX

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

Jun 10, 2025, 8:18 AM EDT - 20 days ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

BNTX MRNA NVAX SNY

Pfizer: Dividend Investor's Dream And Patent Cliff Nightmare

Jun 10, 2025, 4:56 AM EDT - 20 days ago

Pfizer: Dividend Investor's Dream And Patent Cliff Nightmare

Pfizer Inc. (PFE) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Jun 9, 2025, 10:49 AM EDT - 21 days ago

Pfizer Inc. (PFE) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Jun 9, 2025, 9:19 AM EDT - 21 days ago

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

GSK MRK

Pfizer CEO says 'no commitments' made in meetings with US governments on drug pricing

Jun 9, 2025, 8:33 AM EDT - 21 days ago

Pfizer CEO says 'no commitments' made in meetings with US governments on drug pricing

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 10% (June 2025)

Jun 7, 2025, 8:00 AM EDT - 23 days ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 10% (June 2025)

ADP AES AMH ARCC ARE BTI CSL

Buy 7 Ideal 'Safer' May Dividends, Out Of 40 Reader Tags

Jun 6, 2025, 9:01 AM EDT - 24 days ago

Buy 7 Ideal 'Safer' May Dividends, Out Of 40 Reader Tags

AGNC BMA DIA EPD ET FSK GLD

These Stocks Are The High-Yield Dividend Investor's Best Friend

Jun 4, 2025, 7:05 AM EDT - 26 days ago

These Stocks Are The High-Yield Dividend Investor's Best Friend

AMLP ARCC BEP BEPC BIP BIPC ENB

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

Jun 3, 2025, 3:34 PM EDT - 27 days ago

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

AZN GILD AMGN BMY BNTX MRK

Pfizer's R&D Optimization Delivers Great Results & Secure Dividends

Jun 3, 2025, 1:22 PM EDT - 27 days ago

Pfizer's R&D Optimization Delivers Great Results & Secure Dividends

Buy, Sell, Or Hold PFE Stock At $23?

Jun 3, 2025, 10:00 AM EDT - 27 days ago

Buy, Sell, Or Hold PFE Stock At $23?

June's Top 10 High-Yield Stocks: Build A Path To A 10%+ Yield By 2035

Jun 2, 2025, 4:00 PM EDT - 4 weeks ago

June's Top 10 High-Yield Stocks: Build A Path To A 10%+ Yield By 2035

ARCC CNQ CVS CVX JNJ KHC OMC

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Jun 2, 2025, 10:00 AM EDT - 4 weeks ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer (PFE) CEO on Braftovi Reducing Colorectal Cancer Death Risk "in Half"

May 31, 2025, 10:01 AM EDT - 4 weeks ago

Pfizer (PFE) CEO on Braftovi Reducing Colorectal Cancer Death Risk "in Half"

Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression

May 31, 2025, 8:06 AM EDT - 4 weeks ago

Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression

ARVN

Carat Group's Fred Hassan dives into what pharma companies to watch at 2025 ASCO Annual Meeting

May 30, 2025, 12:23 PM EDT - 4 weeks ago

Carat Group's Fred Hassan dives into what pharma companies to watch at 2025 ASCO Annual Meeting

AMGN GSK MRK

Pfizer's BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

May 30, 2025, 8:00 AM EDT - 4 weeks ago

Pfizer's BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Collaborations for Change: AUA and Pfizer Select Recipients for $1.5 Million Grant Program to Improve Advanced Prostate Cancer Care

May 29, 2025, 10:04 AM EDT - 4 weeks ago

Collaborations for Change: AUA and Pfizer Select Recipients for $1.5 Million Grant Program to Improve Advanced Prostate Cancer Care

Hearing Against Pfizer Set For 30 May In Contraceptive ‘Depo-Provera' Multidistrict Litigation Overseen By Levin Papantonio

May 28, 2025, 8:00 AM EDT - 4 weeks ago

Hearing Against Pfizer Set For 30 May In Contraceptive ‘Depo-Provera' Multidistrict Litigation Overseen By Levin Papantonio

Unlocking Pfizer's Value: Cost Controls And Oncology Pipeline

May 27, 2025, 10:12 PM EDT - 4 weeks ago

Unlocking Pfizer's Value: Cost Controls And Oncology Pipeline

Investing In The Promising PD1/VEGF Bispecific - Pfizer And Instil Could Be Good Candidates

May 26, 2025, 1:07 AM EDT - 5 weeks ago

Investing In The Promising PD1/VEGF Bispecific - Pfizer And Instil Could Be Good Candidates

AndrewLonggg
AndrewLonggg Jun. 30 at 9:12 PM
$DJT $PFE $SPY Here is the funny thing. We no longer want to follow the old health expert advice. You would prefer not to follow the new health expert advice. Let’s both decide what we would prefer to do then
0 · Reply
WholeLottaLuv
WholeLottaLuv Jun. 30 at 9:11 PM
$DJT $PFE $SPY You mean the guy with the brain worm, who was a heroin addict for 14 years? Jesus says “Lying is Bad.” Better stop lying and posting MAGA lies, Andrew.
0 · Reply
Shagg85
Shagg85 Jun. 30 at 8:49 PM
$BMY $NUVB $NUVL $PFE $RHHBY pump on your Own ticker. they aren’t even close to release or FDA approval
0 · Reply
BeefSchnitzerlin
BeefSchnitzerlin Jun. 30 at 8:39 PM
$PFE Recent low bounced off the 35 year trendline...
2 · Reply
Quantumup
Quantumup Jun. 30 at 8:39 PM
Goldman Sachs assigned $NUVL at a Buy-$105 after its previous No Rating on their Initiation, plus⬆️its peak sales ests for nela/zide to ~$7B WW non-risk-adj'd, or ~$5B risk-adj'd in 2040. $NUVB $PFE $BMY $RHHBY Goldman Sachs said in its note:
0 · Reply
AndrewLonggg
AndrewLonggg Jun. 30 at 8:32 PM
$DJT $SPY $PFE BREAKING: Robert F. Kennedy Jr. says the CDC covered up an internal study which found a 1135% increase in autism risk from hepatitis B vaccine.
3 · Reply
taxplanr
taxplanr Jun. 30 at 8:26 PM
Texas gubernatorial candidate wants to arrest Fauci $BNTX $MRNA $PFE https://x.com/DiedSuddenly_/status/1939447328244462059
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 30 at 8:00 PM
$PFE Yet another EOD pump that gets shorted back down in the last 5 mins of trading
0 · Reply
_Crim_Jamer_
_Crim_Jamer_ Jun. 30 at 7:52 PM
$PFE my feelings as a $PFE investor.
1 · Reply
HFlier
HFlier Jun. 30 at 7:24 PM
$PFE I don't normally trash talk stocks I am long in, but this one has been such trash for no reason over the last year, I can't help myself. They have good performance and a good pipeline and PE is seriously attractive. But until the Greek moves on, I fear this will just languish. He does not excite the investment community. The activist investors should have worked harder to toss him out. The float is way too high to.
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 30 at 7:22 PM
$PFE https://youtu.be/9AbnbQTTgQs?si=TP9y7ExonDbfgRaf
0 · Reply
BullDonald
BullDonald Jun. 30 at 7:19 PM
$ESPR $PFE
1 · Reply
Quantumup
Quantumup Jun. 30 at 6:48 PM
Raymond James reiterated $BBIO Outperform-$57 and said, "On Monday, BridgeBio announced that they sold a portion of their acoramidis (Attruby U.S./Beyontra ex-U.S.) royalties from Bayer in European territories to HCRx and Blue Owl for $300M." $OWL $BAYZF $ALNY $PFE Raymond James added, "Cash burn and risk of dilution has been an overhang for the company, and the $300M cash infusion, by our model, helps bridge the company into at least 2027, during which we think acoramidis sales will be rapidly inflecting upward. Recall during March 2024 BridgeBio licensed acoramidis in Europe to Bayer in exchange for upfront/milestone payments and royalty rate in the low 30s as a percentage of net sales. Based on our constructive view of the Attruby launch we make no change to our Outperform rating."
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 30 at 6:38 PM
$PFE 3 days of the same shit
1 · Reply
Quantumup
Quantumup Jun. 30 at 6:32 PM
Leerink⬆️ $ZLAB PT to $75 was $73 and reiterated at an Outperform. $AMGN $REGN $BMY $PFE NVCR Leerink said in its note to investors:
0 · Reply
WolfOfLouisiana
WolfOfLouisiana Jun. 30 at 6:28 PM
$PFE 🐺
0 · Reply
Micheal_Pothead
Micheal_Pothead Jun. 30 at 5:57 PM
$PFE I’ve never known a more pathetic stock in my life…
2 · Reply
dust6431
dust6431 Jun. 30 at 5:47 PM
$PFE SMELLS LIKE
0 · Reply
nimii
nimii Jun. 30 at 5:41 PM
$PFE 🥲
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Jun. 30 at 5:39 PM
$PFE - Pfizzing out, huh? So predictable.
0 · Reply
Bullpigbearman
Bullpigbearman Jun. 30 at 5:26 PM
$PFE going very slowly to $30 😂😂 maybe too slow 🐢
0 · Reply
Kingjake26
Kingjake26 Jun. 30 at 5:18 PM
$CAPR Never forget. Time is muscle. No approved therapies FDA will always consider a step forward. This is a big step forward. $XBI $PFE https://youtu.be/zeJ0d47IulY?si=RycN-e3gUiCIX8pU.
1 · Reply